Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
80.98
+1.18 (1.48%)
At close: Jun 26, 2026, 4:00 PM EDT
81.06
+0.08 (0.10%)
After-hours: Jun 26, 2026, 7:57 PM EDT

Medtronic Revenue by Segment

Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Cardiovascular
13.98B 13.51B 13.09B 12.76B 12.48B 12.28B 12.17B 11.99B
Cardiovascular Growth
11.96% 10.08% 7.61% 6.43% 5.49% 2.27% 2.71% 2.50%
Neuroscience
10.29B 10.16B 10.06B 9.95B 9.85B 9.77B 9.67B 9.51B
Neuroscience Growth
4.48% 3.94% 4.01% 4.63% 4.67% 5.38% 5.49% 4.88%
Medical Surgery
8.82B 8.64B 8.54B 8.50B 8.41B 8.39B 8.47B 8.48B
Medical Surgery Growth
4.84% 2.92% 0.80% 0.13% -1.40% -0.70% 0.33% 1.36%
Diabetes
3.11B 3.00B 2.90B 2.83B 2.76B 2.69B 2.63B 2.56B
Diabetes Growth
12.92% 11.72% 10.14% 10.64% 10.73% 10.90% 11.90% 11.22%
Other
174.00M 171.00M 171.00M 173.00M 48.00M 74.00M 59.00M 44.00M
Other Growth
262.50% 131.08% 189.83% 293.18% -57.14% 34.55% 55.26% 175.00%

Revenue by Geography

Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
Rest of World
18.26B 17.70B 17.23B 16.89B 16.37B 16.23B 16.15B 15.86B
Rest of World Growth
11.58% 9.06% 6.74% 6.51% 3.58% 3.90% 5.40% 5.52%
United States
18.10B 17.78B 17.52B 17.31B 17.17B 16.97B 16.85B 16.72B
United States Growth
5.43% 4.80% 4.01% 3.54% 3.67% 1.62% 1.27% 1.14%

Operating Expense Breakdown

Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022
Selling, General, and Administrative
11.78B 11.45B 11.21B 11.00B 10.85B 10.89B 10.85B 10.78B
Selling, General, and Administrative Growth
8.60% 5.09% 3.31% 2.06% 1.05% 2.89% 3.04% 3.04%
Research and Development
2.87B 2.89B 2.84B 2.78B 2.73B 2.72B 2.74B 2.74B
Research and Development Growth
5.16% 5.99% 3.50% 1.38% -0.15% 0.81% 1.82% 2.69%
Amortization
1.77B 1.93B 1.90B 1.85B 1.81B 1.66B 1.67B 1.68B
Amortization Growth
-1.94% 15.94% 14.23% 10.44% 6.80% -2.00% -2.52% -1.58%
Other Expenses
387.00M 142.00M 102.00M 46.00M -23.00M 439.00M 461.00M 464.00M
Other Expenses Growth
- -67.65% -77.87% -90.09% - 920.93% - -
Restructuring
250.00M 279.00M 245.00M 265.00M 267.00M 232.00M 209.00M 219.00M
Restructuring Growth
-6.37% 20.26% 17.22% 21.00% 18.14% -43.14% -50.94% -47.36%
Litigation
112.00M 303.00M 263.00M 263.00M 317.00M 147.00M 125.00M 190.00M
Litigation Growth
-64.67% 106.12% 110.40% 38.42% 112.75% 96.00% 66.67% 1,800.00%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.